Fjarde Ap-fonden’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.22M | Sell |
|
|||||
|
2025
Q2 | $7.43M | Sell |
|
|||||
|
2025
Q1 | $7.48M | Buy |
|
|||||
|
2024
Q4 | $7.59M | Buy |
|
|||||
|
2024
Q3 | $6.14M | Buy |
|
|||||
|
2024
Q1 | $5.8M | Buy |
|
|||||
|
2023
Q4 | $5.08M | Sell |
|
|||||
|
2023
Q3 | $5.03M | Buy |
|
|||||
|
2023
Q2 | $3.48M | Buy |
|
|||||
|
2023
Q1 | $2.62M | Buy |
|
|||||
|
2022
Q4 | $2.6M | Sell |
|
|||||
|
2022
Q3 | $2.64M | Hold |
|
|||||
|
2022
Q2 | $2.64M | Sell |
|
|||||
|
2022
Q1 | $2.65M | Sell |
|
|||||
|
2021
Q4 | $3.06M | Buy |
|
|||||
|
2021
Q3 | $3.29M | Sell |
|
|||||
|
2021
Q2 | $3.61M | Buy |
|
|||||
|
2021
Q1 | $3.4M | Buy |
|
|||||
|
2020
Q4 | $3.28M | Buy |
|
|||||
|
2020
Q3 | $3M | Buy |
|
|||||
|
2020
Q2 | $3.48M | Sell |
|
|||||
|
2020
Q1 | $2.53M | Sell |
|
|||||
|
2019
Q4 | $3.19M | Buy |
|